BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 16771703)

  • 1. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical proteomics: towards early detection of cancers].
    Solassol J; Boulle N; Maudelonde T; Mangé A
    Med Sci (Paris); 2005; 21(8-9):722-9. PubMed ID: 16115457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T; Kato H
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

  • 20. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.